{"transactions":[{"id":3282135,"issuer":{"id":4667,"kind":"organization","name":"Schrodinger, Inc.","symbol":"SDGR"},"owners":[{"id":151828,"kind":"person","name":"WRIGHT TIMOTHY MICHAEL","position":1,"cik":"0001686178","reported_name":"WRIGHT TIMOTHY MICHAEL","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-10T16:09:27.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":12909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest in full on February 5, 2021."}],"balance_after":12909,"derivative":{"exercise_price":17,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":12909},"source":{"system":"sec-edgar","filing":"0000899243-20-003801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686178/000089924320003801/doc4.xml","form_type":"4"}},{"id":3672410,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":151828,"kind":"person","name":"WRIGHT TIMOTHY MICHAEL","position":1,"cik":"0001686178","reported_name":"WRIGHT TIMOTHY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R & D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-06T16:52:33.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0.95,"expiration_date":"2029-02-04","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-19-007778","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686178/000120919119007778/doc4.xml","form_type":"4"}},{"id":3672409,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":151828,"kind":"person","name":"WRIGHT TIMOTHY MICHAEL","position":1,"cik":"0001686178","reported_name":"WRIGHT TIMOTHY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R & D Officer"}}],"security":"Common Stock","published_at":"2019-02-06T16:52:33.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":40000,"price":0.95,"value":38000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units which vest ratably on a quarterly basis such that the grant is fully vested on December 31, 2019, subject to the reporting person's continuous service to Regulus through each such vesting date."}],"balance_after":62893,"source":{"system":"sec-edgar","filing":"0001209191-19-007778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686178/000120919119007778/doc4.xml","form_type":"4"}},{"id":3924121,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":151828,"kind":"person","name":"WRIGHT TIMOTHY MICHAEL","position":1,"cik":"0001686178","reported_name":"WRIGHT TIMOTHY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R & D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-21T16:45:17.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in forty-eight equal monthly installments, such that the option will be fully vested four years from the date of grant, subject to the Reporting Person's continuous service to us."}],"balance_after":350000,"derivative":{"exercise_price":0.71,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-18-031900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686178/000120919118031900/doc4.xml","form_type":"4"}},{"id":4105631,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":151828,"kind":"person","name":"WRIGHT TIMOTHY MICHAEL","position":1,"cik":"0001686178","reported_name":"WRIGHT TIMOTHY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R & D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-05T18:58:02.000Z","date":"2018-01-05","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in forty-eight equal monthly installments, such that the option will be fully vested four years from the date of grant, subject to the Reporting Person's continuous service to us."}],"balance_after":500000,"derivative":{"exercise_price":1.24,"expiration_date":"2028-01-04","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-18-002556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686178/000120919118002556/doc4.xml","form_type":"4"}},{"id":4142185,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":151828,"kind":"person","name":"WRIGHT TIMOTHY MICHAEL","position":1,"cik":"0001686178","reported_name":"WRIGHT TIMOTHY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R & D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-05T09:31:00.000Z","date":"2017-12-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On October 3, 2016, the reporting person was granted an option to purchase 400,000 shares of common stock.  The option vests in increments of 100,000 shares upon the achievement of certain performance criteria.  On December 4, 2017, the performance criteria for the first goal were met, resulting in the vesting of 100,000 shares."}],"balance_after":100000,"derivative":{"exercise_price":3.3,"exercise_date":"2017-12-04","expiration_date":"2026-10-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-17-063711","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686178/000120919117063711/doc4.xml","form_type":"4"}},{"id":4251901,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":151828,"kind":"person","name":"WRIGHT TIMOTHY MICHAEL","position":1,"cik":"0001686178","reported_name":"WRIGHT TIMOTHY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R & D Officer"}}],"security":"Common Stock","published_at":"2017-07-25T18:09:51.000Z","date":"2017-07-25","kind":"purchase","acquired":true,"shares":274725,"price":0.91,"value":249999.75,"ownership":{"direct":true},"balance_after":274725,"source":{"system":"sec-edgar","filing":"0001209191-17-046235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686178/000120919117046235/doc4.xml","form_type":"4"}},{"id":4330252,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":151828,"kind":"person","name":"WRIGHT TIMOTHY MICHAEL","position":1,"cik":"0001686178","reported_name":"WRIGHT TIMOTHY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R & D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-08T16:25:44.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vest on May 4, 2018 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on May 4, 2021."}],"balance_after":350000,"derivative":{"exercise_price":1.7,"expiration_date":"2027-05-03","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001209191-17-030593","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686178/000120919117030593/doc4.xml","form_type":"4"}},{"id":4427906,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":151828,"kind":"person","name":"WRIGHT TIMOTHY MICHAEL","position":1,"cik":"0001686178","reported_name":"WRIGHT TIMOTHY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R & D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-23T17:23:34.000Z","date":"2017-02-15","kind":"grant","acquired":true,"shares":32412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vest on January 1, 2018 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on January 1, 2021."}],"balance_after":32412,"derivative":{"exercise_price":1.2,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":32412},"source":{"system":"sec-edgar","filing":"0001209191-17-013906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686178/000120919117013906/doc4.xml","form_type":"4"}},{"id":4584544,"issuer":{"id":78034,"kind":"organization","name":"Regulus Therapeutics Inc.","symbol":"RGLS"},"owners":[{"id":151828,"kind":"person","name":"WRIGHT TIMOTHY MICHAEL","position":1,"cik":"0001686178","reported_name":"WRIGHT TIMOTHY MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief R & D Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-05T16:59:57.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares vest on October 3, 2017 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that\nthe option is fully vested on October 2, 2021."}],"balance_after":450000,"derivative":{"exercise_price":3.3,"expiration_date":"2026-10-02","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001209191-16-145038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686178/000120919116145038/doc4.xml","form_type":"4"}}]}